Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics
The repositioning or “repurposing” of existing therapies for alternative disease indications is an attractive approach that can save significant investments of time and money during drug development. For cancer indications, the primary goal of repurposed therapies is on efficacy, with less restricti...
Main Authors: | J. Javier Hernandez, Michael Pryszlak, Lindsay Smith, Connor Yanchus, Naheed Kurji, Vijay M. Shahani, Steven V. Molinski |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fonc.2017.00273/full |
Similar Items
-
In Silico Repurposed Drugs against Monkeypox Virus
by: Hilbert Yuen In Lam, et al.
Published: (2022-08-01) -
Strategies for drug repurposing against coronavirus targets
by: Poppy O. Smith, et al.
Published: (2022-01-01) -
Paradoxical Pro-angiogenic Effect of Low-Dose Ellipticine Identified by In Silico Drug Repurposing
by: Jisu Oh, et al.
Published: (2021-08-01) -
Overcoming Therapy Resistance in Colon Cancer by Drug Repurposing
by: Talal El Zarif, et al.
Published: (2022-04-01) -
Preliminary In Vitro and In Vivo Insights of In Silico Candidate Repurposed Drugs for Alzheimer’s Disease
by: Kyriaki Savva, et al.
Published: (2023-04-01)